Caricamento...
The potential role of TNFα in 2019 novel coronavirus pneumonia
The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitis (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.
Salvato in:
| Pubblicato in: | Respir Med Case Rep |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7215148/ https://ncbi.nlm.nih.gov/pubmed/32399393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101087 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|